Anyone who has been investing for any reasonable length of time knows that bear markets are inevitable. It’s just part of the normal cycle of capital flows that swing from risk to safety with little dependable timing or logic. Most of the financial media and experts agree that the definition of a bear market is…
India will soon have its own national gold coins. Metals and Minerals Trading Corporation (MMTC) will manufacture and market the gold coins, set for release in October. According to the Times of India, MMTC managing director Ved Prakash said the company plans to produce two gold coins, one weighing 5 grams and the other 10….
The last 10 days have been fascinating in particular with reference to 2 stocks that have dominated the headlines – Volkwagen (Cars) and Glencore (commodities). VW has suffered a major hit it was a €220 stock 3 months ago, today it closed at around €106 per share with much of the collapse in the last…
On the opening day of Trump Plaza in Atlantic City in 1984, Donald Trump stood in a dark topcoat on the casino floor celebrating his new investment as the “finest building in the city and possibly the nation.” Thirty years later, the Trump Plaza folded, leaving some 1,000 employees without jobs. Trump, meanwhile, was on…
Podcast: Play in new window | Play in new window (Duration: 13:16 — 6.1MB) DOW + 47 = 16,049 SPX + 2 = 1884 NAS – 26 = 4517 10 YR YLD – .04 = 2.09% OIL + .80 = 45.23 GOLD – 4.40 = 1128.70 SILV + .04 = 14.74 Single-family home prices rose…
Multitude of announcements will move the markets With unemployment numbers coming out of Germany, GDP numbers coming out of the United Kingdom, and inventory numbers coming out of the United States for crude oil, it’s very likely that we will have quite a bit of volatility during the session. However, this sets up a nice…
Bear Market Mentality Hits Biotech FBT 110.5 down 1.23% YTD IBB $296 down 2.3% YTD XBI $61.8 flat YTD XLV down 4.74% YTD Fidelity Select Biotech Fund (FBIOX) $212 down 4% YTD Review Previous Articles on Biotech Market Trends The vicious three month sell-off with the IBB down 20% over one month in the six year…
Shares of Esperion Therapeutics (ESPR) tumbled almost 48% today after the company provided an update of its end-of-phase 2 meeting with the FDA. Esperion is a biotechnology company focused on generating treatments for patients with hypercholesterolemia, or high levels of LDL-C — bad cholesterol. The reason for the meeting with the FDA was so that…
It wasn’t a day of carnage like yesterday, and with support coming into play for certain indices there is a chance bulls might be able to mount something here. Volume was down on yesterday, another sign sellers could be exhausting themselves out. The Russell 2000, having exceeded its August, could be the first to mount…
